nach oben

Erschienen in:

12.10.2022 | Original Article

The effects of regular swimming exercise and melatonin on the neurons localized in the striatum of hemiparkinsonian rats

verfasst von: Sinem Gergin, Özlem Kirazlı, Hatice Boracı, Sercan Doğukan Yıldız, Hasan Raci Yananlı, Ümit Süleyman Şehirli

Erschienen in: Anatomical Science International | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Parkinson’s disease is a progressive neurodegenerative movement disorder. We aimed to investigate the effects of regular swimming exercise and melatonin applied in the 6-Hydroxydopamine-induced Parkinson’s disease rats by analysing dendritic spine of striatal neurons. Twenty-four male Wistar albino rats were used. 6-Hydroxydopamine unilaterally injected four (control, exercise, melatonin and exercise + melatonin) groups were included in the study. Tyrosine hydroxylase expression was detected by immunohistochemistry. Neurons and structures were identified from three-dimensional images by Neurolucida software. There was not any apparent difference for tyrosine hydroxylase positive neurons in the substantia nigra pars compacta and fibres in the striatum between the lesion sides of hemiparkinsonian groups. The treatment groups blocked the apomorphine-induced increase in rotations compared to the control group. In stepping test, the treatment groups prevented the loss of stepping in the contralateral side of hemiparkinsonian groups. The melatonin mostly had a positive effect on motor activity tests. In morphological analyses, the 6-Hydroxydopamine-induced lesion led to the reduction of the total dendritic length and number of branches. In the treatment groups, the reduction of the dendritic parameters was not observed. 6-Hydroxydopamine lesion led to a decrease in the total spine density, spine densities of thin and mushroom types. The exercise and melatonin treatments prevented the loss of spine density. The exercise treatment prevented the loss of spine density of mushroom type spines. The melatonin treatment blocked the loss of spine density of stubby type. In conclusion, these results provide evidence for effective additional protective therapeutic strategies for Parkinson’s disease. In conclusion, results from the current study provide evidence for swimming exercise and melatonin as a promising candidate for effective additional protective strategies for PD.

Nur mit Berechtigung zugänglich

Alghamdi BS (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96:1136–1149. https://doi.org/10.1002/jnr.24220CrossRef

Amara AW, Chahine L, Seedorff N, Caspell-Garcia CJ, Coffey C, Simuni T (2019) Self-reported physical activity levels and clinical progression in early Parkinson’s disease. Parkinsonism Relat Disord 61:118–125. https://doi.org/10.1016/j.parkreldis.2018.11.006CrossRef

Arellano JI, Benavides-Piccione R, Defelipe J, Yuste R (2007) Ultrastructure of dendritic spines: correlation between synaptic and spine morphologies. Front Neurosci 1:131–143. https://doi.org/10.3389/neuro.01.1.1.010.2007CrossRef

Askar MH, Hussein AM, Al-Basiony SF, Meseha RK, Metias EF, Salama MM, Antar A, El-Sayed A (2019) Effects of exercise and ferulic acid on alpha synuclein and neuroprotective heat shock protein 70 in an experimental model of Parkinsonism disease. CNS Neurol Disord Drug Targets 18:156–169. https://doi.org/10.2174/1871527317666180816095707CrossRef

Ayán C, Cancela J (2012) Feasibility of 2 different water-based exercise training programs in patients with Parkinson’s disease: a pilot study. Arch Phys Med Rehabil 93:1709–1714. https://doi.org/10.1016/j.apmr.2012.03.029CrossRef

Ayán C, Cancela JM, Gutiérrez-Santiago A, Prieto I (2014) Effects of two different exercise programs on gait parameters in individuals with Parkinson’s disease: a pilot study. Gait Posture 39:648–651. https://doi.org/10.1016/j.gaitpost.2013.08.019CrossRef

Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson’s disease. Front Neuroanat 9:91. https://doi.org/10.3389/fnana.2015.00091CrossRef

Boracı H, Kirazlı Ö, Gülhan R, Yıldız Sercan D, Şehirli ÜS (2020) Neuroprotective effect of regular swimming exercise on calretinin-positive striatal neurons of Parkinsonian rats. Anat Sci Int 95:429–439. https://doi.org/10.1007/s12565-020-00538-yCrossRef

Bourne J, Harris KM (2007) Do thin spines learn to be mushroom spines that remember? Curr Opin Neurobiol 17(3):381-386. https://doi.org/10.1016/j.conb.2007.04.009CrossRef

Bouzid MA, Filaire E, Matran R, Robin S, Fabre C (2018) Lifelong voluntary exercise modulates age-related changes in oxidative stress. Int J Sports Med 39:21–28. https://doi.org/10.1055/s-0043-119882CrossRef

Braak H, Braak E (1985) Golgi preparations as a tool in neuropathology with particular reference to investigations of the human telencephalic cortex. Prog Neurobiol 25:93–139. https://doi.org/10.1016/0301-0082(85)90001-2CrossRef

Burton S, Daya S, Potgieter B (1991) Melatonin modulates apomorphine-induced rotational behaviour. Experientia 47:466–469. https://doi.org/10.1007/BF01959946CrossRef

Chagniel L, Robitaille C, Lebel M, Cyr M (2012) Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model. Neurobiol Dis 45:645–655. https://doi.org/10.1016/j.nbd.2011.10.011CrossRef

Chen W, Chang MH (2010) New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness. Pediatr Neonatol 51:69–79. https://doi.org/10.1016/S1875-9572(10)60014-9CrossRef

Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670–1683. https://doi.org/10.1001/jama.2014.3654CrossRef

Cugusi L, Manca A, Bergamin M, Di Blasio A, Monticone M, Deriu F, Mercuro G (2019) Aquatic exercise improves motor impairments in people with Parkinson’s disease, with similar or greater benefits than land-based exercise: a systematic review. J Physiother 65:65–74. https://doi.org/10.1016/j.jphys.2019.02.003CrossRef

Dani C, Proença IT, Marinho J, Peccin P, da Silva IRV, Nique S, Striebel V, Pochmann D, Elsner VR (2020) Aquatic exercise program-modulated oxidative stress markers in patients with Parkinson’s disease. Neural Regen Res 15:2067–2072. https://doi.org/10.4103/1673-5374.276337CrossRef

Feter N, Spanevello RM, Soares MSP, Spohr L, Pedra NS, Bona NP, Freitas MP, Gonzales NG, Ito LGMS, Stefanello FM, Rombaldi AJ (2019) How does physical activity and different models of exercise training affect oxidative parameters and memory? Physiol Behav 201:42–52. https://doi.org/10.1016/j.physbeh.2018.12.002CrossRef

Filali M, Lalonde R (2016) Neurobehavioral anomalies in the Pitx3/ak murine model of Parkinson’s disease and MPTP. Behav Genet 46:228–241. https://doi.org/10.1007/s10519-015-9753-3CrossRef

Gagnon D, Petryszyn S, Sanchez MG, Bories C, Beaulieu JM, De Koninck Y, Parent A, Parent M (2017) Striatal neurons expressing D1 and D2 receptors are morphologically distinct and differently affected by dopamine denervation in mice. Sci Rep 7:41432. https://doi.org/10.1038/srep41432CrossRef

Gerfen CR (2006) Indirect-pathway neurons lose their spines in Parkinson disease. Nat Neurosci 9:157–158. https://doi.org/10.1038/nn0206-157CrossRef

Gipson CD, Olive MF (2017) Structural and functional plasticity of dendritic spines–root or result of behavior? Genes Brain Behav 16:101–117. https://doi.org/10.1111/gbb.12324CrossRef

Goes AT, Souza LC, Filho CB, Del Fabbro L, De Gomes MG, Boeira SP, Jesse CR (2014) Neuroprotective effects of swimming training in a mouse model of Parkinson’s disease induced by 6-hydroxydopamine. Neuroscience 256:61–71. https://doi.org/10.1016/j.neuroscience.2013.09.042CrossRef

Graves SM, Surmeier DJ (2019) Delayed spine pruning of direct pathway spiny projection neurons in a mouse model of Parkinson’s disease. Front Cell Neurosci 13:32–37. https://doi.org/10.3389/fncel.2019.00032CrossRef

Grutzendler J, Kasthuri N, Gan WB (2002) Long-term dendritic spine stability in the adult cortex. Nature 420:812–816. https://doi.org/10.1038/nature01276CrossRef

Hayashi Y, Majewska AK (2005) Dendritic spine geometry: functional implication and regulation. Neuron 46(4):529–532. https://doi.org/10.1016/j.neuron.2005.05.006CrossRef

Hossain MA, Weiner N (1993) Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson’s disease. J Pharmacol Exp Ther 267:1105–1111

Ingham CA, Hood SH, van Maldegem B, Weenink A, Arbuthnott GW (1993) Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. Exp Brain Res 93:17–27. https://doi.org/10.1007/BF00227776CrossRef

Jacobs B, Driscoll L, Schall M (1997) Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol 386:661–680CrossRef

Khaldy H, Escames G, León J, Bikjdaouene L, Acuña-Castroviejo D (2003) Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion. Neurobiol Aging 24:491–500. https://doi.org/10.1016/s0197-4580(02)00133-1CrossRef

Kim YS, Joo WS, Jin BK, Cho YH, Baik HH, Park CW (1998) Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system. NeuroReport 9:2387–2390. https://doi.org/10.1097/00001756-199807130-00043CrossRef

Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain 136:2419–2431. https://doi.org/10.1093/brain/awt192CrossRef

Lauzé M, Daneault JF, Duval C (2016) The effects of physical activity in Parkinson’s disease: a review. J Parkinsons Dis 6:685–698. https://doi.org/10.3233/JPD-160790CrossRef

Li Y, Wang SM, Guo L, Zhu J, Wang Y, Li L, Zhao YX (2017) Effects of melatonin levels on neurotoxicity of the medial prefrontal cortex in a rat model of Parkinson’s disease. Chin Med J (engl) 130:2726–2731. https://doi.org/10.4103/0366-6999.218025CrossRef

Lin AM, Fang SF, Chao PL, Yang CH (2007) Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein. J Pineal Res 43:163–171. https://doi.org/10.1111/j.1600-079X.2007.00456.xCrossRef

Lin L, Meng T, Liu T, Zheng Z (2013) Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson’s disease. Life Sci 92:311–316. https://doi.org/10.1016/j.lfs.2013.01.007CrossRef

Lin L, Du Y, Yuan S, Shen J, Lin X, Zheng Z (2014) Serum melatonin is an alternative index of Parkinson’s disease severity. Brain Res 1547:43–48. https://doi.org/10.1016/j.brainres.2013.12.021CrossRef

Ma J, Shaw VE, Mitrofanis J (2009) Does melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord 15:307–314. https://doi.org/10.1016/j.parkreldis.2008.07.008CrossRef

Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, Magalhães MC, de Lourdes SM, de Bruin VM (2007) Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease. J Neurol 254:459–464. https://doi.org/10.1007/s00415-006-0390-xCrossRef

Morais LH, Lima MM, Martynhak BJ, Santiago R, Takahashi TT, Ariza D, Barbiero JK, Andreatini R, Vital MA (2012) Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration. Pharmacol Rep 64:1081–1090. https://doi.org/10.1016/s1734-1140(12)70905-2CrossRef

Naskar A, Manivasagam T, Chakraborty J, Singh R, Thomas B, Dhanasekaran M, Mohanakumar KP (2013) Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism. J Pineal Res 55:304–312. https://doi.org/10.1111/jpi.12076CrossRef

Olsson M, Nikkhah G, Bentlage C, Björklund A (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15:3863–3875. https://doi.org/10.1523/JNEUROSCI.15-05-03863.1995CrossRef

Ono K, Mochizuki H, Ikeda T, Nihira T, Takasaki J, Teplow DB, Yamada M (2012) Effect of melatonin on alpha-synuclein self-assembly and cytotoxicity. Neurobiol Aging 33:2172–2185. https://doi.org/10.1016/j.neurobiolaging.2011.10.015CrossRef

Ozsoy O, Yildirim FB, Ogut E, Kaya Y, Tanriover G, Parlak H, Agar A, Aslan M (2015) Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model. Free Radic Res 49:1004–1014. https://doi.org/10.3109/10715762.2015.1027198CrossRef

Paillé V, Henry V, Lescaudron L, Brachet P, Damier P (2007) Rat model of Parkinson’s disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias. Mov Disord 22:533–539. https://doi.org/10.1002/mds.21308CrossRef

Parajuli LK, Wako K, Maruo S, Kakuta S, Taguchi T, Ikuno M, Yamakado H, Takahashi R, Koike M (2020a) Developmental changes in dendritic spine morphology in the striatum and their alteration in an A53T α-synuclein transgenic mouse model of Parkinson’s disease. eNeuro. https://doi.org/10.1523/ENEURO.0072-20.2020aCrossRef

Parajuli LK, Urakubo H, Takahashi-Nakazato A, Ogelman R, Iwasaki H, Koike M, Kwon HB, Ishii S, Oh WC, Fukazawa Y, Okabe S (2020b) Geometry and the organizational principle of spine synapses along a dendrite. eNeuro. https://doi.org/10.1523/ENEURO.0248-20.2020CrossRef

Patki G, Lau YS (2011) Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson’s disease. Pharmacol Biochem Behav 99:704–711. https://doi.org/10.1016/j.pbb.2011.06.026CrossRef

Paul R, Phukan BC, Justin Thenmozhi A, Manivasagam T, Bhattacharya P, Borah A (2018) Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson’s disease. Life Sci 192:238–245. https://doi.org/10.1016/j.lfs.2017.11.016CrossRef

Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, San Diego

Peters A, Kaiserman-Abramof IR (1970) The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines. Am J Anat 127:321–355. https://doi.org/10.1002/aja.1001270402CrossRef

Rammo R, Schwalb JM, Air EL (2019) MRI-guided DBS for Parkinson’s disease. In: Goodman RR Surgery for Parkinson’s Disease. Springer Nature Switzerland AG, 67–79: (1st ed.)

Rasheed MZ, Andrabi SS, Salman M, Tabassum H, Shaquiquzzaman M, Parveen S, Parvez S (2018) Melatonin improves behavioral and biochemical outcomes in a rotenone-induced rat model of Parkinson’s disease. J Environ Pathol Toxicol Oncol 37:139–150. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2018025666CrossRef

Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61:253–278. https://doi.org/10.1111/jpi.12360CrossRef

Samii A, Nutt JG, Ransom BR (2004) Parkinson’s disease. Lancet 363:1783–1793. https://doi.org/10.1016/S0140-6736(04)16305-8CrossRef

Saravanan KS, Sindhu KM, Mohanakumar KP (2007) Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res 42:247–253. https://doi.org/10.1111/j.1600-079X.2006.00412.xCrossRef

Sarkar S, Raymick J, Imam S (2016) Neuroprotective and therapeutic strategies against Parkinson’s disease: Recent perspectives. Int J Mol Sci 17:904–935. https://doi.org/10.3390/ijms17060904CrossRef

Sharma R, McMillan CR, Niles LP (2007) Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson’s disease. J Pineal Res 43:245–254. https://doi.org/10.1111/j.1600-079X.2007.00469.xCrossRef

Shin MS, Kim TW, Lee JM, Sung YH, Lim BV (2017) Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats. J Exerc Rehabil. 13:124–129. https://doi.org/10.12965/jer.1734966.483.

Shirvani H, Aslani J, Mohammadi ZF, Arabzadeh E (2019) Short-term effect of low-, moderate-, and high-intensity exercise training on cerebral dopamine neurotrophic factor (CDNF) and oxidative stress biomarkers in brain male Wistar rats. Comp Clin Pathol 28:369–376. https://doi.org/10.1007/s00580-018-2885-0CrossRef

Shohamy D (2011) Learning and motivation in the human striatum. Curr Opin Neurobiol 21:408–414. https://doi.org/10.1016/j.conb.2011.05.009CrossRef

Sholl DA (1953) Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 87:387–406

Singhal NK, Srivastava G, Patel DK, Jain SK, Singh MP (2011) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson’s disease phenotype in the mouse. J Pineal Res 50:97–109. https://doi.org/10.1111/j.1600-079X.2010.00819.xCrossRef

Smith Y, Villalba RM, Raju DV (2009) Striatal spine plasticity in Parkinson’s disease: pathological or not? Parkinsonism Relat Disord 15:156–161. https://doi.org/10.1016/S1353-8020(09)70805-3CrossRef

Soderstrom KE, O’Malley JA, Levine ND, Sortwell CE, Collier TJ, Steece-Collier K (2010) Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur J Neurosci 31:478–490. https://doi.org/10.1111/j.1460-9568.2010.07077.xCrossRef

Solis O, Limón DI, Flores-Hernández J, Flores G (2007) Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson’s disease. Synapse 61:450–458. https://doi.org/10.1002/syn.20381CrossRef

Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ (2004) Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington’s disease transgenic mice. Eur J Neurosci 19:2799–2807. https://doi.org/10.1111/j.0953-816X.2004.03374.xCrossRef

Spivey A (2011) Rotenone and paraquat linked to Parkinson’s disease: human exposure study supports years of animal studies. Environ Health Perspect 119:A259. https://doi.org/10.1289/ehp.119-a259aCrossRef

Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW, Bell JE, Kilford L, Kingsbury AE, Daniel SE, Ingham CA (2005) Evidence of a breakdown of corticostriatal connections in Parkinson’s disease. Neuroscience 132:741–754. https://doi.org/10.1016/j.neuroscience.2005.01.007CrossRef

Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R (2016) L-DOPA oppositely regulates synaptic strength and spine morphology in D1 and D2 striatal projection neurons in dyskinesia. Cereb Cortex 26:4253–4264. https://doi.org/10.1093/cercor/bhw263CrossRef

Tancheva L, Lazarova M, Saso L, Kalfin R, Stefanova M, Uzunova D, Atanasov AG (2021) Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats. J Mol Neurosci 41:1–11. https://doi.org/10.1007/s12031-020-01760-zCrossRef

Tønnesen J, Katona G, Rózsa B, Nägerl UV (2014) Spine neck plasticity regulates compartmentalization of synapses. Nat Neurosci 17:678–685. https://doi.org/10.1038/nn.3682CrossRef

Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, Vučković MG, Jakowec MW (2014) Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease. Neurobiol Dis 63:201–209. https://doi.org/10.1016/j.nbd.2013.11.017CrossRef

Unzai T, Kuramoto E, Kaneko T, Fujiyama F (2017) Quantitative analyses of the projection of individual neurons from the midline thalamic nuclei to the striosome and matrix compartments of the rat striatum. Cereb Cortex 27:1164–1181. https://doi.org/10.1093/cercor/bhv295CrossRef

Villalba RM, Lee H, Smith Y (2009) Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol 215:220–227. https://doi.org/10.1016/j.expneurol.2008.09.025CrossRef

Villalba RM, Smith Y (2010) Striatal spine plasticity in Parkinson’s disease. Front Neuroanat 4:133–139. https://doi.org/10.3389/fnana.2010.00133CrossRef

Villalba RM, Smith Y (2011a) Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol 519:989–1005. https://doi.org/10.1002/cne.22563CrossRef

Walker RH, Moore C, Davies G, Dirling LB, Koch RJ, Meshul CK (2012) Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. PLoS ONE 7:e32919. https://doi.org/10.1371/journal.pone.0032919CrossRef

Yildirim FB, Ozsoy O, Tanriover G, Kaya Y, Ogut E, Gemici B, Dilmac S, Ozkan A, Agar A, Aslan M (2014) Mechanism of the beneficial effect of melatonin in experimental Parkinson’s disease. Neurochem Int 79:1–11. https://doi.org/10.1016/j.neuint.2014.09.005CrossRef

Yuste R (2010) Dendritic spines. MIT Press, CambridgeCrossRef

Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A, Deutch AY, Montine TJ (2005) Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64:545–547. https://doi.org/10.1212/01.WNL.0000150591.33787.A4CrossRef

Zhao M, Hu C, Wu Z, Chen Y, Li Z, Zhang M (2017) Effects of coordination and manipulation therapy for patients with Parkinson disease. Int J Neurosci 127:762–769. https://doi.org/10.1080/00207454.2016.1248839CrossRef

Titel: The effects of regular swimming exercise and melatonin on the neurons localized in the striatum of hemiparkinsonian rats
verfasst von: Sinem Gergin
Özlem Kirazlı
Hatice Boracı
Sercan Doğukan Yıldız
Hasan Raci Yananlı
Ümit Süleyman Şehirli
Publikationsdatum: 12.10.2022
Verlag: Springer Nature Singapore
Erschienen in: Anatomical Science International / Ausgabe 2/2023
Print ISSN: 1447-6959
Elektronische ISSN: 1447-073X
DOI: https://doi.org/10.1007/s12565-022-00688-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Development of a new histological identification method of human sinoatrial node suitable for immunohistochemical study

A surgical modification in the technique of rat pinealectomy

The thyrocervical trunk: an analysis of its morphology and variations

Morphometric evaluation and classification of the superior orbital fissure on 3D MDCT images

Structural changes and neurotrophic factors upregulation in submandibular gland in a rat model of depression: proposed correlation with stress indicators during and after the relief of depression